nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—SLC6A4—alcohol dependence	0.355	1	CbGaD
Reboxetine—SLC6A4—Citalopram—alcohol dependence	0.108	0.252	CbGbCtD
Reboxetine—SLC6A2—Citalopram—alcohol dependence	0.0899	0.21	CbGbCtD
Reboxetine—HTR2C—Citalopram—alcohol dependence	0.0899	0.21	CbGbCtD
Reboxetine—ABCB1—Naltrexone—alcohol dependence	0.0432	0.101	CbGbCtD
Reboxetine—ABCB1—Citalopram—alcohol dependence	0.0286	0.067	CbGbCtD
Reboxetine—CYP2D6—Citalopram—alcohol dependence	0.027	0.0631	CbGbCtD
Reboxetine—CYP3A4—Disulfiram—alcohol dependence	0.0241	0.0563	CbGbCtD
Reboxetine—CYP3A4—Citalopram—alcohol dependence	0.0171	0.0401	CbGbCtD
Reboxetine—SLC6A2—locus ceruleus—alcohol dependence	0.0052	0.193	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—alcohol dependence	0.00276	0.102	CbGeAlD
Reboxetine—SLC6A2—nerve—alcohol dependence	0.00155	0.0575	CbGeAlD
Reboxetine—HTR2C—brainstem—alcohol dependence	0.000799	0.0296	CbGeAlD
Reboxetine—HTR2C—forebrain—alcohol dependence	0.000771	0.0286	CbGeAlD
Reboxetine—SLC6A4—brainstem—alcohol dependence	0.000757	0.0281	CbGeAlD
Reboxetine—SLC6A4—forebrain—alcohol dependence	0.000731	0.0271	CbGeAlD
Reboxetine—SLC6A2—brainstem—alcohol dependence	0.000667	0.0247	CbGeAlD
Reboxetine—Diphenylpyraline—SLC6A3—alcohol dependence	0.000645	0.183	CrCbGaD
Reboxetine—SLC6A2—forebrain—alcohol dependence	0.000643	0.0238	CbGeAlD
Reboxetine—Benzatropine—CHRM2—alcohol dependence	0.000568	0.161	CrCbGaD
Reboxetine—SLC6A4—digestive system—alcohol dependence	0.000513	0.019	CbGeAlD
Reboxetine—HTR2C—midbrain—alcohol dependence	0.000509	0.0189	CbGeAlD
Reboxetine—Benzatropine—SLC6A3—alcohol dependence	0.000494	0.14	CrCbGaD
Reboxetine—SLC6A2—gonad—alcohol dependence	0.000494	0.0183	CbGeAlD
Reboxetine—SLC6A4—blood—alcohol dependence	0.000489	0.0181	CbGeAlD
Reboxetine—SLC6A4—midbrain—alcohol dependence	0.000483	0.0179	CbGeAlD
Reboxetine—HTR2C—Monoamine GPCRs—DRD4—alcohol dependence	0.000472	0.00948	CbGpPWpGaD
Reboxetine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000467	0.00937	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—alcohol dependence	0.00046	0.00924	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR1B—alcohol dependence	0.000454	0.00912	CbGpPWpGaD
Reboxetine—Irritability—Naltrexone—alcohol dependence	0.000441	0.0032	CcSEcCtD
Reboxetine—Thinking abnormal—Citalopram—alcohol dependence	0.00044	0.00319	CcSEcCtD
Reboxetine—HTR2C—Monoamine GPCRs—DRD2—alcohol dependence	0.00044	0.00884	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR7—alcohol dependence	0.00044	0.00884	CbGpPWpGaD
Reboxetine—Glossitis—Citalopram—alcohol dependence	0.000437	0.00317	CcSEcCtD
Reboxetine—Paraesthesia—Disulfiram—alcohol dependence	0.000437	0.00317	CcSEcCtD
Reboxetine—Somnolence—Disulfiram—alcohol dependence	0.000433	0.00314	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00043	0.00312	CcSEcCtD
Reboxetine—Dehydration—Naltrexone—alcohol dependence	0.000429	0.00311	CcSEcCtD
Reboxetine—Hypercholesterolaemia—Citalopram—alcohol dependence	0.000426	0.00309	CcSEcCtD
Reboxetine—SLC6A4—endocrine gland—alcohol dependence	0.000424	0.0157	CbGeAlD
Reboxetine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000422	0.00848	CbGpPWpGaD
Reboxetine—Influenza—Acamprosate—alcohol dependence	0.000422	0.00306	CcSEcCtD
Reboxetine—HTR2C—nervous system—alcohol dependence	0.000418	0.0155	CbGeAlD
Reboxetine—Coordination abnormal—Citalopram—alcohol dependence	0.00041	0.00298	CcSEcCtD
Reboxetine—Blood uric acid increased—Citalopram—alcohol dependence	0.00041	0.00298	CcSEcCtD
Reboxetine—SLC6A4—NRF2 pathway—ADH7—alcohol dependence	0.000408	0.0082	CbGpPWpGaD
Reboxetine—Neck pain—Citalopram—alcohol dependence	0.000408	0.00296	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000407	0.00295	CcSEcCtD
Reboxetine—Bronchitis—Acamprosate—alcohol dependence	0.000406	0.00294	CcSEcCtD
Reboxetine—HTR2C—central nervous system—alcohol dependence	0.000403	0.0149	CbGeAlD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000402	0.00807	CbGpPWpGaD
Reboxetine—Influenza—Naltrexone—alcohol dependence	0.000399	0.00289	CcSEcCtD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD4—alcohol dependence	0.000397	0.00797	CbGpPWpGaD
Reboxetine—SLC6A4—nervous system—alcohol dependence	0.000397	0.0147	CbGeAlD
Reboxetine—SLC6A4—NRF2 pathway—GGT2—alcohol dependence	0.000391	0.00786	CbGpPWpGaD
Reboxetine—Salivary hypersecretion—Citalopram—alcohol dependence	0.000391	0.00284	CcSEcCtD
Reboxetine—Pollakiuria—Acamprosate—alcohol dependence	0.00039	0.00283	CcSEcCtD
Reboxetine—Urinary incontinence—Citalopram—alcohol dependence	0.000389	0.00282	CcSEcCtD
Reboxetine—Erectile dysfunction—Acamprosate—alcohol dependence	0.000388	0.00282	CcSEcCtD
Reboxetine—Bronchitis—Naltrexone—alcohol dependence	0.000384	0.00278	CcSEcCtD
Reboxetine—SLC6A4—central nervous system—alcohol dependence	0.000382	0.0142	CbGeAlD
Reboxetine—Weight decreased—Acamprosate—alcohol dependence	0.000382	0.00277	CcSEcCtD
Reboxetine—Hyperglycaemia—Acamprosate—alcohol dependence	0.00038	0.00276	CcSEcCtD
Reboxetine—SLC6A2—endocrine gland—alcohol dependence	0.000373	0.0138	CbGeAlD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD2—alcohol dependence	0.00037	0.00743	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR7—alcohol dependence	0.00037	0.00743	CbGpPWpGaD
Reboxetine—Urinary tract infection—Acamprosate—alcohol dependence	0.000365	0.00265	CcSEcCtD
Reboxetine—CYP2D6—brainstem—alcohol dependence	0.000365	0.0135	CbGeAlD
Reboxetine—Weight decreased—Naltrexone—alcohol dependence	0.000361	0.00262	CcSEcCtD
Reboxetine—Sweating—Acamprosate—alcohol dependence	0.00036	0.00261	CcSEcCtD
Reboxetine—SLC6A2—testis—alcohol dependence	0.000356	0.0132	CbGeAlD
Reboxetine—Infestation NOS—Naltrexone—alcohol dependence	0.000356	0.00258	CcSEcCtD
Reboxetine—Infestation—Naltrexone—alcohol dependence	0.000356	0.00258	CcSEcCtD
Reboxetine—Epistaxis—Acamprosate—alcohol dependence	0.000355	0.00257	CcSEcCtD
Reboxetine—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.000353	0.00709	CbGpPWpGaD
Reboxetine—CYP2D6—forebrain—alcohol dependence	0.000352	0.0131	CbGeAlD
Reboxetine—Hyperkinesia—Citalopram—alcohol dependence	0.000351	0.00255	CcSEcCtD
Reboxetine—SLC6A2—NRF2 pathway—ADH7—alcohol dependence	0.000351	0.00705	CbGpPWpGaD
Reboxetine—Mental disability—Citalopram—alcohol dependence	0.00035	0.00254	CcSEcCtD
Reboxetine—Asthenia—Disulfiram—alcohol dependence	0.000349	0.00253	CcSEcCtD
Reboxetine—SLC6A2—nervous system—alcohol dependence	0.000349	0.0129	CbGeAlD
Reboxetine—Atomoxetine—HTR1B—alcohol dependence	0.000349	0.0988	CrCbGaD
Reboxetine—Euphoric mood—Citalopram—alcohol dependence	0.000346	0.00251	CcSEcCtD
Reboxetine—Conjunctivitis—Naltrexone—alcohol dependence	0.000346	0.00251	CcSEcCtD
Reboxetine—Urinary tract infection—Naltrexone—alcohol dependence	0.000346	0.00251	CcSEcCtD
Reboxetine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000345	0.00693	CbGpPWpGaD
Reboxetine—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000339	0.00682	CbGpPWpGaD
Reboxetine—Rhinitis—Acamprosate—alcohol dependence	0.000338	0.00245	CcSEcCtD
Reboxetine—SLC6A2—NRF2 pathway—GGT2—alcohol dependence	0.000337	0.00676	CbGpPWpGaD
Reboxetine—SLC6A2—central nervous system—alcohol dependence	0.000336	0.0125	CbGeAlD
Reboxetine—Hallucination—Acamprosate—alcohol dependence	0.000336	0.00244	CcSEcCtD
Reboxetine—Epistaxis—Naltrexone—alcohol dependence	0.000336	0.00243	CcSEcCtD
Reboxetine—Pharyngitis—Acamprosate—alcohol dependence	0.000335	0.00243	CcSEcCtD
Reboxetine—Sinusitis—Naltrexone—alcohol dependence	0.000334	0.00242	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000333	0.00668	CbGpPWpGaD
Reboxetine—Gastroenteritis—Citalopram—alcohol dependence	0.00033	0.00239	CcSEcCtD
Reboxetine—Visual impairment—Acamprosate—alcohol dependence	0.000325	0.00236	CcSEcCtD
Reboxetine—Dizziness—Disulfiram—alcohol dependence	0.000322	0.00234	CcSEcCtD
Reboxetine—HTR2C—brain—alcohol dependence	0.00032	0.0119	CbGeAlD
Reboxetine—Hallucination—Naltrexone—alcohol dependence	0.000318	0.0023	CcSEcCtD
Reboxetine—Pharyngitis—Naltrexone—alcohol dependence	0.000317	0.0023	CcSEcCtD
Reboxetine—Libido decreased—Citalopram—alcohol dependence	0.000315	0.00229	CcSEcCtD
Reboxetine—Atomoxetine—SLC6A3—alcohol dependence	0.000315	0.0893	CrCbGaD
Reboxetine—Tinnitus—Acamprosate—alcohol dependence	0.000315	0.00228	CcSEcCtD
Reboxetine—Connective tissue disorder—Naltrexone—alcohol dependence	0.000314	0.00228	CcSEcCtD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2A—alcohol dependence	0.000308	0.00619	CbGpPWpGaD
Reboxetine—Rash—Disulfiram—alcohol dependence	0.000307	0.00223	CcSEcCtD
Reboxetine—Headache—Disulfiram—alcohol dependence	0.000305	0.00221	CcSEcCtD
Reboxetine—Immune system disorder—Acamprosate—alcohol dependence	0.000305	0.00221	CcSEcCtD
Reboxetine—SLC6A4—brain—alcohol dependence	0.000303	0.0112	CbGeAlD
Reboxetine—Chills—Acamprosate—alcohol dependence	0.000303	0.0022	CcSEcCtD
Reboxetine—Eye disorder—Naltrexone—alcohol dependence	0.000298	0.00216	CcSEcCtD
Reboxetine—Tinnitus—Naltrexone—alcohol dependence	0.000298	0.00216	CcSEcCtD
Reboxetine—Cardiac disorder—Naltrexone—alcohol dependence	0.000296	0.00215	CcSEcCtD
Reboxetine—Mental disorder—Acamprosate—alcohol dependence	0.000296	0.00214	CcSEcCtD
Reboxetine—Malnutrition—Acamprosate—alcohol dependence	0.000294	0.00213	CcSEcCtD
Reboxetine—Hyponatraemia—Citalopram—alcohol dependence	0.000294	0.00213	CcSEcCtD
Reboxetine—Diplopia—Citalopram—alcohol dependence	0.000292	0.00212	CcSEcCtD
Reboxetine—Diphenhydramine—CHRM2—alcohol dependence	0.000292	0.0828	CrCbGaD
Reboxetine—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00029	0.0021	CcSEcCtD
Reboxetine—Angiopathy—Naltrexone—alcohol dependence	0.00029	0.0021	CcSEcCtD
Reboxetine—Immune system disorder—Naltrexone—alcohol dependence	0.000288	0.00209	CcSEcCtD
Reboxetine—Tension—Acamprosate—alcohol dependence	0.000288	0.00209	CcSEcCtD
Reboxetine—Mediastinal disorder—Naltrexone—alcohol dependence	0.000288	0.00209	CcSEcCtD
Reboxetine—Dysgeusia—Acamprosate—alcohol dependence	0.000288	0.00209	CcSEcCtD
Reboxetine—Chills—Naltrexone—alcohol dependence	0.000287	0.00208	CcSEcCtD
Reboxetine—Psychotic disorder—Citalopram—alcohol dependence	0.000286	0.00207	CcSEcCtD
Reboxetine—Nervousness—Acamprosate—alcohol dependence	0.000285	0.00207	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000283	0.00568	CbGpPWpGaD
Reboxetine—Face oedema—Citalopram—alcohol dependence	0.000282	0.00205	CcSEcCtD
Reboxetine—Mental disorder—Naltrexone—alcohol dependence	0.00028	0.00203	CcSEcCtD
Reboxetine—Irritability—Citalopram—alcohol dependence	0.000279	0.00202	CcSEcCtD
Reboxetine—Urinary retention—Citalopram—alcohol dependence	0.000278	0.00202	CcSEcCtD
Reboxetine—Malnutrition—Naltrexone—alcohol dependence	0.000278	0.00202	CcSEcCtD
Reboxetine—Orphenadrine—CHRM2—alcohol dependence	0.000276	0.0783	CrCbGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000276	0.00554	CbGpPWpGaD
Reboxetine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000276	0.00554	CbGpPWpGaD
Reboxetine—Tremor—Acamprosate—alcohol dependence	0.000275	0.002	CcSEcCtD
Reboxetine—Tension—Naltrexone—alcohol dependence	0.000273	0.00198	CcSEcCtD
Reboxetine—Ill-defined disorder—Acamprosate—alcohol dependence	0.000273	0.00198	CcSEcCtD
Reboxetine—Dysgeusia—Naltrexone—alcohol dependence	0.000272	0.00197	CcSEcCtD
Reboxetine—Dehydration—Citalopram—alcohol dependence	0.000272	0.00197	CcSEcCtD
Reboxetine—Anaemia—Acamprosate—alcohol dependence	0.000272	0.00197	CcSEcCtD
Reboxetine—Liver function test abnormal—Citalopram—alcohol dependence	0.00027	0.00196	CcSEcCtD
Reboxetine—Agitation—Acamprosate—alcohol dependence	0.00027	0.00196	CcSEcCtD
Reboxetine—Nervousness—Naltrexone—alcohol dependence	0.00027	0.00196	CcSEcCtD
Reboxetine—Orthostatic hypotension—Citalopram—alcohol dependence	0.000267	0.00194	CcSEcCtD
Reboxetine—SLC6A2—brain—alcohol dependence	0.000267	0.00989	CbGeAlD
Reboxetine—Malaise—Acamprosate—alcohol dependence	0.000265	0.00192	CcSEcCtD
Reboxetine—Breast disorder—Citalopram—alcohol dependence	0.000264	0.00192	CcSEcCtD
Reboxetine—Vertigo—Acamprosate—alcohol dependence	0.000264	0.00191	CcSEcCtD
Reboxetine—Syncope—Acamprosate—alcohol dependence	0.000263	0.00191	CcSEcCtD
Reboxetine—Leukopenia—Acamprosate—alcohol dependence	0.000263	0.00191	CcSEcCtD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000263	0.00527	CbGpPWpGaD
Reboxetine—Tremor—Naltrexone—alcohol dependence	0.00026	0.00189	CcSEcCtD
Reboxetine—Palpitations—Acamprosate—alcohol dependence	0.00026	0.00188	CcSEcCtD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2A—alcohol dependence	0.000259	0.0052	CbGpPWpGaD
Reboxetine—Loss of consciousness—Acamprosate—alcohol dependence	0.000258	0.00187	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000258	0.00187	CcSEcCtD
Reboxetine—Muscular weakness—Citalopram—alcohol dependence	0.000258	0.00187	CcSEcCtD
Reboxetine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000258	0.00187	CcSEcCtD
Reboxetine—Agitation—Naltrexone—alcohol dependence	0.000255	0.00185	CcSEcCtD
Reboxetine—Hypertension—Acamprosate—alcohol dependence	0.000254	0.00184	CcSEcCtD
Reboxetine—ABCB1—forebrain—alcohol dependence	0.000253	0.00939	CbGeAlD
Reboxetine—Influenza—Citalopram—alcohol dependence	0.000253	0.00183	CcSEcCtD
Reboxetine—CYP3A4—digestive system—alcohol dependence	0.000251	0.00931	CbGeAlD
Reboxetine—Malaise—Naltrexone—alcohol dependence	0.000251	0.00182	CcSEcCtD
Reboxetine—Chest pain—Acamprosate—alcohol dependence	0.00025	0.00181	CcSEcCtD
Reboxetine—Syncope—Naltrexone—alcohol dependence	0.000249	0.00181	CcSEcCtD
Reboxetine—Anxiety—Acamprosate—alcohol dependence	0.000249	0.00181	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000248	0.0018	CcSEcCtD
Reboxetine—CYP2D6—digestive system—alcohol dependence	0.000247	0.00916	CbGeAlD
Reboxetine—Discomfort—Acamprosate—alcohol dependence	0.000247	0.00179	CcSEcCtD
Reboxetine—Palpitations—Naltrexone—alcohol dependence	0.000246	0.00178	CcSEcCtD
Reboxetine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000245	0.00492	CbGpPWpGaD
Reboxetine—Dry mouth—Acamprosate—alcohol dependence	0.000245	0.00177	CcSEcCtD
Reboxetine—Loss of consciousness—Naltrexone—alcohol dependence	0.000244	0.00177	CcSEcCtD
Reboxetine—Bronchitis—Citalopram—alcohol dependence	0.000243	0.00176	CcSEcCtD
Reboxetine—Confusional state—Acamprosate—alcohol dependence	0.000242	0.00175	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000241	0.00483	CbGpPWpGaD
Reboxetine—Hypertension—Naltrexone—alcohol dependence	0.00024	0.00174	CcSEcCtD
Reboxetine—CYP3A4—blood—alcohol dependence	0.000239	0.00887	CbGeAlD
Reboxetine—Infection—Acamprosate—alcohol dependence	0.000238	0.00173	CcSEcCtD
Reboxetine—Chest pain—Naltrexone—alcohol dependence	0.000237	0.00172	CcSEcCtD
Reboxetine—Dysuria—Citalopram—alcohol dependence	0.000236	0.00171	CcSEcCtD
Reboxetine—Shock—Acamprosate—alcohol dependence	0.000236	0.00171	CcSEcCtD
Reboxetine—Anxiety—Naltrexone—alcohol dependence	0.000236	0.00171	CcSEcCtD
Reboxetine—CYP2D6—blood—alcohol dependence	0.000236	0.00873	CbGeAlD
Reboxetine—Atomoxetine—SLC6A4—alcohol dependence	0.000235	0.0667	CrCbGaD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000235	0.0017	CcSEcCtD
Reboxetine—ABCB1—adrenal cortex—alcohol dependence	0.000235	0.0087	CbGeAlD
Reboxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.000234	0.00471	CbGpPWpGaD
Reboxetine—Tachycardia—Acamprosate—alcohol dependence	0.000234	0.0017	CcSEcCtD
Reboxetine—Discomfort—Naltrexone—alcohol dependence	0.000234	0.0017	CcSEcCtD
Reboxetine—Pollakiuria—Citalopram—alcohol dependence	0.000234	0.00169	CcSEcCtD
Reboxetine—Skin disorder—Acamprosate—alcohol dependence	0.000233	0.00169	CcSEcCtD
Reboxetine—Erectile dysfunction—Citalopram—alcohol dependence	0.000233	0.00169	CcSEcCtD
Reboxetine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000232	0.00168	CcSEcCtD
Reboxetine—Dry mouth—Naltrexone—alcohol dependence	0.000231	0.00168	CcSEcCtD
Reboxetine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000231	0.00464	CbGpPWpGaD
Reboxetine—Confusional state—Naltrexone—alcohol dependence	0.000229	0.00166	CcSEcCtD
Reboxetine—Weight decreased—Citalopram—alcohol dependence	0.000229	0.00166	CcSEcCtD
Reboxetine—Anorexia—Acamprosate—alcohol dependence	0.000229	0.00166	CcSEcCtD
Reboxetine—Hyperglycaemia—Citalopram—alcohol dependence	0.000228	0.00165	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.000227	0.00456	CbGpPWpGaD
Reboxetine—Infection—Naltrexone—alcohol dependence	0.000225	0.00163	CcSEcCtD
Reboxetine—Infestation—Citalopram—alcohol dependence	0.000225	0.00163	CcSEcCtD
Reboxetine—Infestation NOS—Citalopram—alcohol dependence	0.000225	0.00163	CcSEcCtD
Reboxetine—Hypotension—Acamprosate—alcohol dependence	0.000224	0.00163	CcSEcCtD
Reboxetine—Shock—Naltrexone—alcohol dependence	0.000223	0.00162	CcSEcCtD
Reboxetine—Nervous system disorder—Naltrexone—alcohol dependence	0.000222	0.00161	CcSEcCtD
Reboxetine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000222	0.00446	CbGpPWpGaD
Reboxetine—Tachycardia—Naltrexone—alcohol dependence	0.000221	0.00161	CcSEcCtD
Reboxetine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000221	0.00443	CbGpPWpGaD
Reboxetine—Skin disorder—Naltrexone—alcohol dependence	0.00022	0.0016	CcSEcCtD
Reboxetine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000219	0.00159	CcSEcCtD
Reboxetine—Urinary tract infection—Citalopram—alcohol dependence	0.000219	0.00159	CcSEcCtD
Reboxetine—Conjunctivitis—Citalopram—alcohol dependence	0.000219	0.00159	CcSEcCtD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000218	0.00437	CbGpPWpGaD
Reboxetine—Insomnia—Acamprosate—alcohol dependence	0.000217	0.00157	CcSEcCtD
Reboxetine—Anorexia—Naltrexone—alcohol dependence	0.000216	0.00157	CcSEcCtD
Reboxetine—Sweating—Citalopram—alcohol dependence	0.000216	0.00157	CcSEcCtD
Reboxetine—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000216	0.00433	CbGpPWpGaD
Reboxetine—Paraesthesia—Acamprosate—alcohol dependence	0.000215	0.00156	CcSEcCtD
Reboxetine—ABCB1—cardiovascular system—alcohol dependence	0.000214	0.00794	CbGeAlD
Reboxetine—Dyspnoea—Acamprosate—alcohol dependence	0.000214	0.00155	CcSEcCtD
Reboxetine—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000213	0.00428	CbGpPWpGaD
Reboxetine—Somnolence—Acamprosate—alcohol dependence	0.000213	0.00155	CcSEcCtD
Reboxetine—Epistaxis—Citalopram—alcohol dependence	0.000213	0.00154	CcSEcCtD
Reboxetine—Sinusitis—Citalopram—alcohol dependence	0.000211	0.00153	CcSEcCtD
Reboxetine—Dyspepsia—Acamprosate—alcohol dependence	0.000211	0.00153	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000211	0.00424	CbGpPWpGaD
Reboxetine—Decreased appetite—Acamprosate—alcohol dependence	0.000208	0.00151	CcSEcCtD
Reboxetine—ABCB1—pancreas—alcohol dependence	0.000208	0.00772	CbGeAlD
Reboxetine—CYP3A4—endocrine gland—alcohol dependence	0.000208	0.00769	CbGeAlD
Reboxetine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000207	0.0015	CcSEcCtD
Reboxetine—Bradycardia—Citalopram—alcohol dependence	0.000206	0.00149	CcSEcCtD
Reboxetine—Insomnia—Naltrexone—alcohol dependence	0.000205	0.00149	CcSEcCtD
Reboxetine—Constipation—Acamprosate—alcohol dependence	0.000205	0.00149	CcSEcCtD
Reboxetine—CYP2D6—endocrine gland—alcohol dependence	0.000204	0.00757	CbGeAlD
Reboxetine—Paraesthesia—Naltrexone—alcohol dependence	0.000204	0.00148	CcSEcCtD
Reboxetine—Rhinitis—Citalopram—alcohol dependence	0.000203	0.00147	CcSEcCtD
Reboxetine—Dyspnoea—Naltrexone—alcohol dependence	0.000202	0.00147	CcSEcCtD
Reboxetine—Somnolence—Naltrexone—alcohol dependence	0.000202	0.00146	CcSEcCtD
Reboxetine—Hallucination—Citalopram—alcohol dependence	0.000201	0.00146	CcSEcCtD
Reboxetine—Pharyngitis—Citalopram—alcohol dependence	0.000201	0.00146	CcSEcCtD
Reboxetine—Urinary tract disorder—Citalopram—alcohol dependence	0.0002	0.00145	CcSEcCtD
Reboxetine—Connective tissue disorder—Citalopram—alcohol dependence	0.000199	0.00144	CcSEcCtD
Reboxetine—Urethral disorder—Citalopram—alcohol dependence	0.000198	0.00144	CcSEcCtD
Reboxetine—Feeling abnormal—Acamprosate—alcohol dependence	0.000198	0.00143	CcSEcCtD
Reboxetine—Decreased appetite—Naltrexone—alcohol dependence	0.000197	0.00143	CcSEcCtD
Reboxetine—SLC6A4—NRF2 pathway—SLC6A3—alcohol dependence	0.000197	0.00395	CbGpPWpGaD
Reboxetine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000196	0.00142	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000196	0.00142	CcSEcCtD
Reboxetine—Visual impairment—Citalopram—alcohol dependence	0.000195	0.00141	CcSEcCtD
Reboxetine—CYP2D6—testis—alcohol dependence	0.000195	0.00722	CbGeAlD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.000195	0.00391	CbGpPWpGaD
Reboxetine—ABCB1—gonad—alcohol dependence	0.000194	0.00721	CbGeAlD
Reboxetine—CYP3A4—nervous system—alcohol dependence	0.000194	0.0072	CbGeAlD
Reboxetine—Constipation—Naltrexone—alcohol dependence	0.000194	0.00141	CcSEcCtD
Reboxetine—CYP2D6—nervous system—alcohol dependence	0.000191	0.00709	CbGeAlD
Reboxetine—Urticaria—Acamprosate—alcohol dependence	0.00019	0.00138	CcSEcCtD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A4—alcohol dependence	0.00019	0.00381	CbGpPWpGaD
Reboxetine—Abdominal pain—Acamprosate—alcohol dependence	0.00019	0.00138	CcSEcCtD
Reboxetine—Body temperature increased—Acamprosate—alcohol dependence	0.00019	0.00138	CcSEcCtD
Reboxetine—Eye disorder—Citalopram—alcohol dependence	0.000189	0.00137	CcSEcCtD
Reboxetine—Tinnitus—Citalopram—alcohol dependence	0.000189	0.00137	CcSEcCtD
Reboxetine—Cardiac disorder—Citalopram—alcohol dependence	0.000188	0.00136	CcSEcCtD
Reboxetine—CYP3A4—liver—alcohol dependence	0.000187	0.00694	CbGeAlD
Reboxetine—CYP3A4—central nervous system—alcohol dependence	0.000187	0.00693	CbGeAlD
Reboxetine—Feeling abnormal—Naltrexone—alcohol dependence	0.000187	0.00136	CcSEcCtD
Reboxetine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000186	0.00135	CcSEcCtD
Reboxetine—SLC6A4—NRF2 pathway—GGT1—alcohol dependence	0.000185	0.00372	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000185	0.00372	CbGpPWpGaD
Reboxetine—CYP2D6—liver—alcohol dependence	0.000184	0.00683	CbGeAlD
Reboxetine—CYP2D6—central nervous system—alcohol dependence	0.000184	0.00682	CbGeAlD
Reboxetine—SLC6A4—Circadian rythm related genes—CRH—alcohol dependence	0.000184	0.00369	CbGpPWpGaD
Reboxetine—Angiopathy—Citalopram—alcohol dependence	0.000184	0.00133	CcSEcCtD
Reboxetine—Immune system disorder—Citalopram—alcohol dependence	0.000183	0.00133	CcSEcCtD
Reboxetine—Mediastinal disorder—Citalopram—alcohol dependence	0.000182	0.00132	CcSEcCtD
Reboxetine—Chills—Citalopram—alcohol dependence	0.000182	0.00132	CcSEcCtD
Reboxetine—Atomoxetine—HTR2A—alcohol dependence	0.000181	0.0513	CrCbGaD
Reboxetine—Urticaria—Naltrexone—alcohol dependence	0.00018	0.00131	CcSEcCtD
Reboxetine—CYP2D6—cerebellum—alcohol dependence	0.00018	0.00667	CbGeAlD
Reboxetine—Abdominal pain—Naltrexone—alcohol dependence	0.000179	0.0013	CcSEcCtD
Reboxetine—Body temperature increased—Naltrexone—alcohol dependence	0.000179	0.0013	CcSEcCtD
Reboxetine—ABCB1—digestive system—alcohol dependence	0.000178	0.00659	CbGeAlD
Reboxetine—Mental disorder—Citalopram—alcohol dependence	0.000177	0.00129	CcSEcCtD
Reboxetine—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000177	0.00355	CbGpPWpGaD
Reboxetine—Hypersensitivity—Acamprosate—alcohol dependence	0.000177	0.00128	CcSEcCtD
Reboxetine—Malnutrition—Citalopram—alcohol dependence	0.000176	0.00128	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000175	0.00351	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000174	0.0035	CbGpPWpGaD
Reboxetine—Tension—Citalopram—alcohol dependence	0.000173	0.00125	CcSEcCtD
Reboxetine—Dysgeusia—Citalopram—alcohol dependence	0.000172	0.00125	CcSEcCtD
Reboxetine—Orphenadrine—CYP2E1—alcohol dependence	0.000172	0.0488	CrCbGaD
Reboxetine—Asthenia—Acamprosate—alcohol dependence	0.000172	0.00125	CcSEcCtD
Reboxetine—Nervousness—Citalopram—alcohol dependence	0.000171	0.00124	CcSEcCtD
Reboxetine—ABCB1—blood—alcohol dependence	0.000169	0.00628	CbGeAlD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A3—alcohol dependence	0.000169	0.00339	CbGpPWpGaD
Reboxetine—ABCB1—midbrain—alcohol dependence	0.000167	0.0062	CbGeAlD
Reboxetine—Hypersensitivity—Naltrexone—alcohol dependence	0.000167	0.00121	CcSEcCtD
Reboxetine—Tremor—Citalopram—alcohol dependence	0.000165	0.0012	CcSEcCtD
Reboxetine—Diarrhoea—Acamprosate—alcohol dependence	0.000164	0.00119	CcSEcCtD
Reboxetine—Ill-defined disorder—Citalopram—alcohol dependence	0.000163	0.00119	CcSEcCtD
Reboxetine—Anaemia—Citalopram—alcohol dependence	0.000163	0.00118	CcSEcCtD
Reboxetine—Asthenia—Naltrexone—alcohol dependence	0.000163	0.00118	CcSEcCtD
Reboxetine—Agitation—Citalopram—alcohol dependence	0.000162	0.00117	CcSEcCtD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD4—alcohol dependence	0.000161	0.00322	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—GGT1—alcohol dependence	0.000159	0.0032	CbGpPWpGaD
Reboxetine—Malaise—Citalopram—alcohol dependence	0.000159	0.00115	CcSEcCtD
Reboxetine—Dizziness—Acamprosate—alcohol dependence	0.000159	0.00115	CcSEcCtD
Reboxetine—Vertigo—Citalopram—alcohol dependence	0.000158	0.00115	CcSEcCtD
Reboxetine—Syncope—Citalopram—alcohol dependence	0.000158	0.00115	CcSEcCtD
Reboxetine—Leukopenia—Citalopram—alcohol dependence	0.000158	0.00114	CcSEcCtD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000157	0.00316	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000157	0.00316	CbGpPWpGaD
Reboxetine—Palpitations—Citalopram—alcohol dependence	0.000156	0.00113	CcSEcCtD
Reboxetine—Diarrhoea—Naltrexone—alcohol dependence	0.000155	0.00113	CcSEcCtD
Reboxetine—Loss of consciousness—Citalopram—alcohol dependence	0.000155	0.00112	CcSEcCtD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000154	0.0031	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.000153	0.00307	CbGpPWpGaD
Reboxetine—Vomiting—Acamprosate—alcohol dependence	0.000152	0.00111	CcSEcCtD
Reboxetine—Hypertension—Citalopram—alcohol dependence	0.000152	0.0011	CcSEcCtD
Reboxetine—Rash—Acamprosate—alcohol dependence	0.000151	0.0011	CcSEcCtD
Reboxetine—Dermatitis—Acamprosate—alcohol dependence	0.000151	0.0011	CcSEcCtD
Reboxetine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000151	0.00303	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.00015	0.00302	CbGpPWpGaD
Reboxetine—Headache—Acamprosate—alcohol dependence	0.00015	0.00109	CcSEcCtD
Reboxetine—Dizziness—Naltrexone—alcohol dependence	0.00015	0.00109	CcSEcCtD
Reboxetine—Chest pain—Citalopram—alcohol dependence	0.00015	0.00109	CcSEcCtD
Reboxetine—SLC6A4—Circadian rythm related genes—HTR7—alcohol dependence	0.00015	0.003	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD2—alcohol dependence	0.00015	0.003	CbGpPWpGaD
Reboxetine—Anxiety—Citalopram—alcohol dependence	0.000149	0.00108	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000149	0.00108	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000149	0.00299	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000148	0.00298	CbGpPWpGaD
Reboxetine—Discomfort—Citalopram—alcohol dependence	0.000148	0.00107	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—OPRK1—alcohol dependence	0.000148	0.00298	CbGpPWpGaD
Reboxetine—ABCB1—endocrine gland—alcohol dependence	0.000147	0.00545	CbGeAlD
Reboxetine—Dry mouth—Citalopram—alcohol dependence	0.000147	0.00106	CcSEcCtD
Reboxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000147	0.00294	CbGpPWpGaD
Reboxetine—CYP2D6—brain—alcohol dependence	0.000146	0.00542	CbGeAlD
Reboxetine—Confusional state—Citalopram—alcohol dependence	0.000145	0.00105	CcSEcCtD
Reboxetine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000145	0.00291	CbGpPWpGaD
Reboxetine—Vomiting—Naltrexone—alcohol dependence	0.000144	0.00105	CcSEcCtD
Reboxetine—Rash—Naltrexone—alcohol dependence	0.000143	0.00104	CcSEcCtD
Reboxetine—Dermatitis—Naltrexone—alcohol dependence	0.000143	0.00104	CcSEcCtD
Reboxetine—Infection—Citalopram—alcohol dependence	0.000143	0.00104	CcSEcCtD
Reboxetine—Nausea—Acamprosate—alcohol dependence	0.000142	0.00103	CcSEcCtD
Reboxetine—Headache—Naltrexone—alcohol dependence	0.000142	0.00103	CcSEcCtD
Reboxetine—Shock—Citalopram—alcohol dependence	0.000141	0.00103	CcSEcCtD
Reboxetine—Nervous system disorder—Citalopram—alcohol dependence	0.000141	0.00102	CcSEcCtD
Reboxetine—Tachycardia—Citalopram—alcohol dependence	0.00014	0.00102	CcSEcCtD
Reboxetine—ABCB1—testis—alcohol dependence	0.00014	0.00519	CbGeAlD
Reboxetine—Skin disorder—Citalopram—alcohol dependence	0.00014	0.00101	CcSEcCtD
Reboxetine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000139	0.0028	CbGpPWpGaD
Reboxetine—Hyperhidrosis—Citalopram—alcohol dependence	0.000139	0.00101	CcSEcCtD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000138	0.00277	CbGpPWpGaD
Reboxetine—ABCB1—nervous system—alcohol dependence	0.000138	0.0051	CbGeAlD
Reboxetine—Anorexia—Citalopram—alcohol dependence	0.000137	0.000994	CcSEcCtD
Reboxetine—Nausea—Naltrexone—alcohol dependence	0.000135	0.000978	CcSEcCtD
Reboxetine—Hypotension—Citalopram—alcohol dependence	0.000134	0.000974	CcSEcCtD
Reboxetine—ABCB1—liver—alcohol dependence	0.000132	0.00491	CbGeAlD
Reboxetine—ABCB1—central nervous system—alcohol dependence	0.000132	0.00491	CbGeAlD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000131	0.00263	CbGpPWpGaD
Reboxetine—Insomnia—Citalopram—alcohol dependence	0.00013	0.000943	CcSEcCtD
Reboxetine—ABCB1—cerebellum—alcohol dependence	0.000129	0.0048	CbGeAlD
Reboxetine—Paraesthesia—Citalopram—alcohol dependence	0.000129	0.000936	CcSEcCtD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000128	0.00258	CbGpPWpGaD
Reboxetine—Dyspnoea—Citalopram—alcohol dependence	0.000128	0.00093	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.000128	0.00257	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000128	0.00257	CbGpPWpGaD
Reboxetine—Somnolence—Citalopram—alcohol dependence	0.000128	0.000927	CcSEcCtD
Reboxetine—Dyspepsia—Citalopram—alcohol dependence	0.000127	0.000918	CcSEcCtD
Reboxetine—SLC6A4—Circadian rythm related genes—AVP—alcohol dependence	0.000126	0.00253	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000125	0.00252	CbGpPWpGaD
Reboxetine—Decreased appetite—Citalopram—alcohol dependence	0.000125	0.000906	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000124	0.0009	CcSEcCtD
Reboxetine—Constipation—Citalopram—alcohol dependence	0.000123	0.000892	CcSEcCtD
Reboxetine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000123	0.00246	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000119	0.00239	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000119	0.00238	CbGpPWpGaD
Reboxetine—Feeling abnormal—Citalopram—alcohol dependence	0.000118	0.000859	CcSEcCtD
Reboxetine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000118	0.000853	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.000117	0.00236	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000116	0.00232	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000114	0.0023	CbGpPWpGaD
Reboxetine—Urticaria—Citalopram—alcohol dependence	0.000114	0.000828	CcSEcCtD
Reboxetine—Abdominal pain—Citalopram—alcohol dependence	0.000114	0.000824	CcSEcCtD
Reboxetine—Body temperature increased—Citalopram—alcohol dependence	0.000114	0.000824	CcSEcCtD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000112	0.00226	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000112	0.00225	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00011	0.0022	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000107	0.00214	CbGpPWpGaD
Reboxetine—Hypersensitivity—Citalopram—alcohol dependence	0.000106	0.000768	CcSEcCtD
Reboxetine—ABCB1—brain—alcohol dependence	0.000105	0.0039	CbGeAlD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000104	0.00209	CbGpPWpGaD
Reboxetine—Asthenia—Citalopram—alcohol dependence	0.000103	0.000748	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000101	0.00202	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—OPRD1—alcohol dependence	9.96e-05	0.002	CbGpPWpGaD
Reboxetine—Diarrhoea—Citalopram—alcohol dependence	9.84e-05	0.000713	CcSEcCtD
Reboxetine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	9.83e-05	0.00197	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	9.78e-05	0.00196	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	9.72e-05	0.00195	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	9.58e-05	0.00192	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	9.56e-05	0.00192	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—PDYN—alcohol dependence	9.55e-05	0.00192	CbGpPWpGaD
Reboxetine—Dizziness—Citalopram—alcohol dependence	9.51e-05	0.00069	CcSEcCtD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	9.46e-05	0.0019	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	9.29e-05	0.00187	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	9.26e-05	0.00186	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—AVP—alcohol dependence	9.24e-05	0.00186	CbGpPWpGaD
Reboxetine—Vomiting—Citalopram—alcohol dependence	9.14e-05	0.000663	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	9.11e-05	0.00183	CbGpPWpGaD
Reboxetine—Rash—Citalopram—alcohol dependence	9.06e-05	0.000657	CcSEcCtD
Reboxetine—Dermatitis—Citalopram—alcohol dependence	9.06e-05	0.000657	CcSEcCtD
Reboxetine—Headache—Citalopram—alcohol dependence	9.01e-05	0.000653	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	8.93e-05	0.00179	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CRHR1—alcohol dependence	8.87e-05	0.00178	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	8.81e-05	0.00177	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	8.7e-05	0.00175	CbGpPWpGaD
Reboxetine—Nausea—Citalopram—alcohol dependence	8.54e-05	0.000619	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	8.49e-05	0.00171	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	8.49e-05	0.00171	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—OPRK1—alcohol dependence	8.37e-05	0.00168	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	8.36e-05	0.00168	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CHRM2—alcohol dependence	8.34e-05	0.00168	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	8.27e-05	0.00166	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	8.01e-05	0.00161	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	7.9e-05	0.00159	CbGpPWpGaD
Reboxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	7.85e-05	0.00158	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	7.81e-05	0.00157	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	7.77e-05	0.00156	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—alcohol dependence	7.69e-05	0.00154	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—OPRM1—alcohol dependence	7.66e-05	0.00154	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—OPRK1—alcohol dependence	7.6e-05	0.00153	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	7.45e-05	0.0015	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	7.33e-05	0.00147	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	7.27e-05	0.00146	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	7.27e-05	0.00146	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—NPY—alcohol dependence	7.05e-05	0.00142	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	6.88e-05	0.00138	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CRH—alcohol dependence	6.8e-05	0.00137	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR1B—alcohol dependence	6.8e-05	0.00137	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—EP300—alcohol dependence	6.8e-05	0.00137	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	6.39e-05	0.00128	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	6.37e-05	0.00128	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	6.31e-05	0.00127	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	6.23e-05	0.00125	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	6.12e-05	0.00123	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	6.07e-05	0.00122	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	5.95e-05	0.00119	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD4—alcohol dependence	5.95e-05	0.00119	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	5.8e-05	0.00116	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CNR1—alcohol dependence	5.68e-05	0.00114	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—OPRD1—alcohol dependence	5.63e-05	0.00113	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—EP300—alcohol dependence	5.55e-05	0.00111	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD2—alcohol dependence	5.54e-05	0.00111	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR7—alcohol dependence	5.54e-05	0.00111	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	5.41e-05	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PDYN—alcohol dependence	5.39e-05	0.00108	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	5.19e-05	0.00104	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	5.16e-05	0.00104	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	5.13e-05	0.00103	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	5.12e-05	0.00103	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—OPRD1—alcohol dependence	5.11e-05	0.00103	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	5.09e-05	0.00102	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CRHR1—alcohol dependence	5.02e-05	0.00101	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	4.95e-05	0.000995	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PDYN—alcohol dependence	4.9e-05	0.000984	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CHRM2—alcohol dependence	4.72e-05	0.000947	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—AVP—alcohol dependence	4.66e-05	0.000936	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CRHR1—alcohol dependence	4.55e-05	0.000915	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OPRK1—alcohol dependence	4.49e-05	0.000902	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—AVP—alcohol dependence	4.48e-05	0.000899	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—OPRM1—alcohol dependence	4.33e-05	0.00087	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CHRM2—alcohol dependence	4.28e-05	0.00086	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	4.21e-05	0.000846	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	4.16e-05	0.000836	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	4.13e-05	0.000829	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	4.07e-05	0.000817	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.07e-05	0.000817	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—NPY—alcohol dependence	3.98e-05	0.0008	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—OPRM1—alcohol dependence	3.93e-05	0.00079	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—alcohol dependence	3.88e-05	0.000779	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH6—alcohol dependence	3.87e-05	0.000778	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1B—alcohol dependence	3.84e-05	0.000772	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CRH—alcohol dependence	3.84e-05	0.000772	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	3.79e-05	0.000761	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH6—alcohol dependence	3.65e-05	0.000733	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NPY—alcohol dependence	3.62e-05	0.000727	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1B—alcohol dependence	3.49e-05	0.000701	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CRH—alcohol dependence	3.49e-05	0.000701	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	3.4e-05	0.000682	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—POMC—alcohol dependence	3.38e-05	0.000679	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD4—alcohol dependence	3.36e-05	0.000675	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CNR1—alcohol dependence	3.21e-05	0.000644	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH1A—alcohol dependence	3.21e-05	0.000644	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR7—alcohol dependence	3.13e-05	0.000629	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD2—alcohol dependence	3.13e-05	0.000629	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—POMC—alcohol dependence	3.1e-05	0.000622	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD4—alcohol dependence	3.05e-05	0.000613	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH1A—alcohol dependence	3.02e-05	0.000607	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OPRD1—alcohol dependence	3.02e-05	0.000606	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CNR1—alcohol dependence	2.91e-05	0.000585	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDYN—alcohol dependence	2.89e-05	0.000581	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR7—alcohol dependence	2.84e-05	0.000571	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD2—alcohol dependence	2.84e-05	0.000571	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH4—alcohol dependence	2.73e-05	0.000548	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CRHR1—alcohol dependence	2.69e-05	0.00054	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WASF2—alcohol dependence	2.69e-05	0.00054	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AVP—alcohol dependence	2.63e-05	0.000529	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WASF1—alcohol dependence	2.58e-05	0.000518	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH4—alcohol dependence	2.57e-05	0.000516	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CHRM2—alcohol dependence	2.53e-05	0.000508	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AVP—alcohol dependence	2.39e-05	0.000481	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH6—alcohol dependence	2.39e-05	0.000479	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.38e-05	0.000479	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—OPRM1—alcohol dependence	2.32e-05	0.000466	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH7—alcohol dependence	2.32e-05	0.000466	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GGT2—alcohol dependence	2.22e-05	0.000447	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.21e-05	0.000444	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—alcohol dependence	2.19e-05	0.00044	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.19e-05	0.00044	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH7—alcohol dependence	2.19e-05	0.000439	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPY—alcohol dependence	2.14e-05	0.000429	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GGT2—alcohol dependence	2.1e-05	0.000421	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1B—alcohol dependence	2.06e-05	0.000414	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CRH—alcohol dependence	2.06e-05	0.000414	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADH1B—alcohol dependence	2.03e-05	0.000408	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—alcohol dependence	1.99e-05	0.0004	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.98e-05	0.000397	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.97e-05	0.000396	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.92e-05	0.000385	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD4—alcohol dependence	1.8e-05	0.000362	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—POMC—alcohol dependence	1.75e-05	0.000352	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CNR1—alcohol dependence	1.72e-05	0.000346	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOB—alcohol dependence	1.69e-05	0.000338	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH4—alcohol dependence	1.68e-05	0.000338	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD2—alcohol dependence	1.68e-05	0.000337	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR7—alcohol dependence	1.68e-05	0.000337	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—alcohol dependence	1.59e-05	0.000319	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOB—alcohol dependence	1.59e-05	0.000319	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDH2—alcohol dependence	1.43e-05	0.000288	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH7—alcohol dependence	1.43e-05	0.000287	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AVP—alcohol dependence	1.41e-05	0.000284	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GGT2—alcohol dependence	1.37e-05	0.000275	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.35e-05	0.000271	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.25e-05	0.000252	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GOT2—alcohol dependence	1.22e-05	0.000245	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—alcohol dependence	1.18e-05	0.000236	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GOT2—alcohol dependence	1.15e-05	0.000231	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.15e-05	0.00023	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.08e-05	0.000217	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GOT1—alcohol dependence	1.05e-05	0.000211	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GGT1—alcohol dependence	1.05e-05	0.000211	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOB—alcohol dependence	1.04e-05	0.000209	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GOT1—alcohol dependence	9.91e-06	0.000199	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GGT1—alcohol dependence	9.91e-06	0.000199	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOA—alcohol dependence	9.42e-06	0.000189	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—alcohol dependence	9.39e-06	0.000189	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOA—alcohol dependence	8.88e-06	0.000178	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDH2—alcohol dependence	8.83e-06	0.000177	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GOT2—alcohol dependence	7.51e-06	0.000151	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	7.06e-06	0.000142	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GOT1—alcohol dependence	6.48e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GGT1—alcohol dependence	6.48e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EP300—alcohol dependence	6.23e-06	0.000125	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—alcohol dependence	6.14e-06	0.000123	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOA—alcohol dependence	5.81e-06	0.000117	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—alcohol dependence	5.78e-06	0.000116	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—EP300—alcohol dependence	4.07e-06	8.18e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—EP300—alcohol dependence	3.84e-06	7.7e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—alcohol dependence	3.78e-06	7.59e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—EP300—alcohol dependence	2.51e-06	5.04e-05	CbGpPWpGaD
